CVS halts federal probe with $22M settlement; Theorem Clinical Research opens facility in Germany;

> CVS ($CVS) will pay $22 million to settle a federal investigation into whether two of its Florida pharmacies were illegally selling painkillers not prescribed for legitimate uses. Story

> U.S. CRO Theorem Clinical Research is opening a clinical supplies facility in Frankfurt, Germany, in June. Report

> The U.K. is asking the industry to help it fight superbugs. Story

Suggested Articles

President Trump is set to issue an executive order centering on U.S. production for drugs and medical supplies, and pharma is sure to push back. 

The lawmakers question Kodak's fitness for such a major pharma manufacturing deal, as well as suspicious stock transactions by company leadership.

AZ's China COVID-19 vaccine deal comes after supply agreements with the U.S., the U.K., EU and Brazil, as well as licensing pacts in India and Japan.